Commentary on “Sipuleucel-T immunotherapy for castration-resistant prostate cancer”. Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF; IMPACT Study Investigators, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA: Collaborators (84)

✍ Scribed by Donald L. Trump

• Book ID: 116956800
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 72 KB
• Volume: 29
• Category: Article
• ISSN: 1078-1439
• DOI: 10.1016/j.urolonc.2011.01.012